See how top analysts and institutions rate CLSK — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| JP Morgan | Downgrade | Overweight → Neutral | $14 | 2025-09-26 |
| Ladenburg Thalmann | Initiated | Buy | $20.25 | 2025-07-28 |
| B. Riley Securities | Initiated | Buy | $16 | 2025-07-01 |
| Chardan Capital Markets | Resumed | Buy | $20 | 2025-05-21 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 7 | 2 | 0 | 0 |
| October 2025 | 3 | 7 | 2 | 0 | 0 |
| September 2025 | 3 | 7 | 2 | 0 | 0 |
| August 2025 | 4 | 7 | 1 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CLSK, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
